Dublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Pen Needles Company Evaluation" report has been added to ResearchAndMarkets.com's offering. The Pen Needles Companies Quadrant is a comprehensive ...
The new line of insulin pen needles is said to provide healthcare professionals with a range of needle gauges and sizes. Credit: JFontan / Shutterstock.com. Trividia Health UK has launched the ...
[Image courtesy of Trividia Health] Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK. The new five-bevel pen needle provides healthcare ...
March 4 (Reuters) - South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority said ...
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for low-income health clinics. By Katie Thomas Maricruz Salgado was bringing her ...
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin pens to $1 per device in low- and middle-income countries (LMICs). Pens are ...
Insulin therapy is essential for managing diabetes. It includes various methods such as basal-bolus, fixed-dose, pump, pen, and inhaler therapies. These therapies help control blood sugar levels, ...
Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off
Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Diabetes device maker Embecta has hired advisers to explore a possible sale, following two years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results